Search

… Job Title Postdoctoral Fellow Degree PhD Email [email protected] Lab Phone 646-888-3669

Dr. Alexis Chidi explains how MSK uses advanced procedures and same-day pathology to diagnose lung cancer quickly.

… Dr. Alexis Chidi explains how MSK uses advanced procedures and same-day pathology to diagnose lung cancer quickly. Here at MSK, the thoracic surgeons do several diagnostic procedures. These include things like endobronchial ultrasound, which is a way for us to identify whether there’s cancer in any of

Whether someone with cancer is in the hospital, at home, or in a long-term care facility, effective pain management is an essential part of comprehensive cancer care. Learn about your options.

… Whether someone with cancer is in the hospital, at home, or in a long-term care facility, effective pain management is an essential part of comprehensive cancer care. Hospital stays are usually short. Pain related to cancer is most often managed after people return home. For some cancer survivors, pain

… Job Title Research Technician

… Faure L, Soldatov R , Kharchenko PV, Adameyko I. scFates: a scalable python package for advanced pseudotime and bifurcation analysis from single-cell data. Bioinformatics. 2023 Jan 1;39(1):btac746. doi: 10.1093/bioinformatics/btac746. PMID: 36394263; PMCID: PMC9805561. Gao T, Soldatov R , Sarkar H, Kurkiewicz

… Job Title Graduate Research Assistant

Living with scars and other changes to physical appearance after cancer treatment can impact a person’s emotional well-being and quality of life. This lecture will address the survivor experience and discuss techniques to help cope with the emotional impact of post-treatment body changes.

… Job Title Research Scholar

A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment.

… Thursday, August 8, 2019 Summary Wilms’ tumor is the most common kidney cancer in children. Researchers have detected a protein called prohibitin in the urine of people with aggressive Wilms’ tumor. This discovery could help doctors identify people at risk for the cancer returning after treatment and

A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer, regardless of prior CDK 4/6 inhibitors, ESR1 or PI3K pathway mutations.

… Wednesday, December 11, 2024 A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative (ER